Protection against SARS-CoV-2 Omicron BA.4/5 variant following booster vaccination or breakthrough infection in the UK.
Saved in:
| Title: | Protection against SARS-CoV-2 Omicron BA.4/5 variant following booster vaccination or breakthrough infection in the UK. |
|---|---|
| Authors: | Wei J; Nuffield Department of Medicine, University of Oxford, Oxford, UK.; Big Data Institute, Nuffield Department of Population Health, University of Oxford, Oxford, UK., Matthews PC; Nuffield Department of Medicine, University of Oxford, Oxford, UK.; The Francis Crick Institute, 1 Midland Road, London, UK.; Division of infection and immunity, University College London, London, UK., Stoesser N; Nuffield Department of Medicine, University of Oxford, Oxford, UK.; Department of Infectious Diseases and Microbiology, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, UK.; The National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance at the University of Oxford, Oxford, UK.; The National Institute for Health Research Oxford Biomedical Research Centre, University of Oxford, Oxford, UK., Newton JN; European Centre for Environment and Human Health, University of Exeter, Truro, UK., Diamond I; Office for National Statistics, Newport, UK., Studley R; Office for National Statistics, Newport, UK., Taylor N; Office for National Statistics, Newport, UK., Bell JI; Office of the Regius Professor of Medicine, University of Oxford, Oxford, UK., Farrar J; Wellcome Trust, London, UK., Kolenchery J; Nuffield Department of Medicine, University of Oxford, Oxford, UK.; Department of Infectious Diseases and Microbiology, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, UK., Marsden BD; Nuffield Department of Medicine, University of Oxford, Oxford, UK.; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK., Hoosdally S; Nuffield Department of Medicine, University of Oxford, Oxford, UK., Jones EY; Nuffield Department of Medicine, University of Oxford, Oxford, UK., Stuart DI; Nuffield Department of Medicine, University of Oxford, Oxford, UK., Crook DW; Nuffield Department of Medicine, University of Oxford, Oxford, UK.; Department of Infectious Diseases and Microbiology, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, UK.; The National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance at the University of Oxford, Oxford, UK.; The National Institute for Health Research Oxford Biomedical Research Centre, University of Oxford, Oxford, UK., Peto TEA; Nuffield Department of Medicine, University of Oxford, Oxford, UK.; Department of Infectious Diseases and Microbiology, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, UK.; The National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance at the University of Oxford, Oxford, UK.; The National Institute for Health Research Oxford Biomedical Research Centre, University of Oxford, Oxford, UK., Walker AS; Nuffield Department of Medicine, University of Oxford, Oxford, UK.; Big Data Institute, Nuffield Department of Population Health, University of Oxford, Oxford, UK.; The National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance at the University of Oxford, Oxford, UK.; MRC Clinical Trials Unit at UCL, UCL, London, UK., Pouwels KB; The National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance at the University of Oxford, Oxford, UK.; Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford, UK., Eyre DW; Big Data Institute, Nuffield Department of Population Health, University of Oxford, Oxford, UK. david.eyre@bdi.ox.ac.uk.; Department of Infectious Diseases and Microbiology, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, UK. david.eyre@bdi.ox.ac.uk.; The National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance at the University of Oxford, Oxford, UK. david.eyre@bdi.ox.ac.uk.; The National Institute for Health Research Oxford Biomedical Research Centre, University of Oxford, Oxford, UK. david.eyre@bdi.ox.ac.uk. |
| Corporate Authors: | COVID-19 Infection Survey team |
| Source: | Nature communications [Nat Commun] 2023 May 16; Vol. 14 (1), pp. 2799. Date of Electronic Publication: 2023 May 16. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 37193713 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Protection against SARS-CoV-2 Omicron BA.4/5 variant following booster vaccination or breakthrough infection in the UK. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Wei+J%22">Wei J</searchLink>; Nuffield Department of Medicine, University of Oxford, Oxford, UK.; Big Data Institute, Nuffield Department of Population Health, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Matthews+PC%22">Matthews PC</searchLink>; Nuffield Department of Medicine, University of Oxford, Oxford, UK.; The Francis Crick Institute, 1 Midland Road, London, UK.; Division of infection and immunity, University College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Stoesser+N%22">Stoesser N</searchLink>; Nuffield Department of Medicine, University of Oxford, Oxford, UK.; Department of Infectious Diseases and Microbiology, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, UK.; The National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance at the University of Oxford, Oxford, UK.; The National Institute for Health Research Oxford Biomedical Research Centre, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Newton+JN%22">Newton JN</searchLink>; European Centre for Environment and Human Health, University of Exeter, Truro, UK.<br /><searchLink fieldCode="AU" term="%22Diamond+I%22">Diamond I</searchLink>; Office for National Statistics, Newport, UK.<br /><searchLink fieldCode="AU" term="%22Studley+R%22">Studley R</searchLink>; Office for National Statistics, Newport, UK.<br /><searchLink fieldCode="AU" term="%22Taylor+N%22">Taylor N</searchLink>; Office for National Statistics, Newport, UK.<br /><searchLink fieldCode="AU" term="%22Bell+JI%22">Bell JI</searchLink>; Office of the Regius Professor of Medicine, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Farrar+J%22">Farrar J</searchLink>; Wellcome Trust, London, UK.<br /><searchLink fieldCode="AU" term="%22Kolenchery+J%22">Kolenchery J</searchLink>; Nuffield Department of Medicine, University of Oxford, Oxford, UK.; Department of Infectious Diseases and Microbiology, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Marsden+BD%22">Marsden BD</searchLink>; Nuffield Department of Medicine, University of Oxford, Oxford, UK.; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Hoosdally+S%22">Hoosdally S</searchLink>; Nuffield Department of Medicine, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Jones+EY%22">Jones EY</searchLink>; Nuffield Department of Medicine, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Stuart+DI%22">Stuart DI</searchLink>; Nuffield Department of Medicine, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Crook+DW%22">Crook DW</searchLink>; Nuffield Department of Medicine, University of Oxford, Oxford, UK.; Department of Infectious Diseases and Microbiology, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, UK.; The National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance at the University of Oxford, Oxford, UK.; The National Institute for Health Research Oxford Biomedical Research Centre, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Peto+TEA%22">Peto TEA</searchLink>; Nuffield Department of Medicine, University of Oxford, Oxford, UK.; Department of Infectious Diseases and Microbiology, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, UK.; The National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance at the University of Oxford, Oxford, UK.; The National Institute for Health Research Oxford Biomedical Research Centre, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Walker+AS%22">Walker AS</searchLink>; Nuffield Department of Medicine, University of Oxford, Oxford, UK.; Big Data Institute, Nuffield Department of Population Health, University of Oxford, Oxford, UK.; The National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance at the University of Oxford, Oxford, UK.; MRC Clinical Trials Unit at UCL, UCL, London, UK.<br /><searchLink fieldCode="AU" term="%22Pouwels+KB%22">Pouwels KB</searchLink>; The National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance at the University of Oxford, Oxford, UK.; Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Eyre+DW%22">Eyre DW</searchLink>; Big Data Institute, Nuffield Department of Population Health, University of Oxford, Oxford, UK. david.eyre@bdi.ox.ac.uk.; Department of Infectious Diseases and Microbiology, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, UK. david.eyre@bdi.ox.ac.uk.; The National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance at the University of Oxford, Oxford, UK. david.eyre@bdi.ox.ac.uk.; The National Institute for Health Research Oxford Biomedical Research Centre, University of Oxford, Oxford, UK. david.eyre@bdi.ox.ac.uk. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22COVID-19+Infection+Survey+team%22">COVID-19 Infection Survey team</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101528555%22">Nature communications</searchLink> [Nat Commun] 2023 May 16; Vol. 14 (1), pp. 2799. <i>Date of Electronic Publication: </i>2023 May 16. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101528555 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-1723 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220411723%22">20411723 </searchLink><i>NLM ISO Abbreviation: </i>Nat Commun <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37193713 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41467-023-38275-1 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 2799 Titles: – TitleFull: Protection against SARS-CoV-2 Omicron BA.4/5 variant following booster vaccination or breakthrough infection in the UK. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Wei J – PersonEntity: Name: NameFull: Matthews PC – PersonEntity: Name: NameFull: Stoesser N – PersonEntity: Name: NameFull: Newton JN – PersonEntity: Name: NameFull: Diamond I – PersonEntity: Name: NameFull: Studley R – PersonEntity: Name: NameFull: Taylor N – PersonEntity: Name: NameFull: Bell JI – PersonEntity: Name: NameFull: Farrar J – PersonEntity: Name: NameFull: Kolenchery J – PersonEntity: Name: NameFull: Marsden BD – PersonEntity: Name: NameFull: Hoosdally S – PersonEntity: Name: NameFull: Jones EY – PersonEntity: Name: NameFull: Stuart DI – PersonEntity: Name: NameFull: Crook DW – PersonEntity: Name: NameFull: Peto TEA – PersonEntity: Name: NameFull: Walker AS – PersonEntity: Name: NameFull: Pouwels KB – PersonEntity: Name: NameFull: Eyre DW IsPartOfRelationships: – BibEntity: Dates: – D: 16 M: 05 Text: 2023 May 16 Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 2041-1723 Numbering: – Type: volume Value: 14 – Type: issue Value: 1 Titles: – TitleFull: Nature communications Type: main |
| ResultId | 1 |